ghit fund

GHIT Awards Seven New Grants Amounting To US$15.3 Million

Research in the neglected tropical diseases of dengue, malaria and Chagas disease receive a US$15.3 million boost in funding from GHIT.

US$12 Million In Grants Awarded For Neglected Diseases

Japan's Global Health Initiative Technology Fund has committed US$12 million in grants for neglected diseases and a potential tuberculosis vaccine.

Takeda, MMV Partner To Study Anti-Malarial Compounds

Takeda Pharma will collaborate with Medicines for Malaria Venture to study two new anti-malarial compounds.